Literature DB >> 11066136

Prognostic significance of entrapped liver cells in hepatic metastases from colorectal cancer.

M Koike1, K Yasui, A Torii, S Kodama.   

Abstract

OBJECTIVE: To correlate the microscopic finding of entrapped liver cells in hepatic metastases from colorectal cancer with outcome after hepatectomy. SUMMARY BACKGROUND DATA: Reliable histopathologic prognostic factors in resected liver metastases from colorectal cancer have not been identified.
METHODS: Seventy-one patients undergoing radical hepatectomy for liver metastases were assigned to rare (n = 36) or frequent (n = 35) groups according to the microscopically observed frequency of hepatocyte entrapment in the tumor.
RESULTS: Five-year survival rates after hepatectomy were 44. 4% for the rare group and 27.2% for the frequent group. Multivariate analysis using the Cox proportional hazards model by a stepwise method identified this morphologic variable as a significant independent prognostic factor.
CONCLUSIONS: The finding of entrapped liver cells in metastases from colorectal cancer reflects the biologic activity of the tumor and may be a useful prognostic indicator.

Entities:  

Mesh:

Year:  2000        PMID: 11066136      PMCID: PMC1421219          DOI: 10.1097/00000658-200011000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

1.  Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin.

Authors:  K Shirabe; K Takenaka; T Gion; Y Fujiwara; M Shimada; K Yanaga; T Maeda; K Kajiyama; K Sugimachi
Journal:  Br J Surg       Date:  1997-08       Impact factor: 6.939

2.  Clinical anatomic aspects of radical hepatic surgery.

Authors:  J E HEALEY
Journal:  J Int Coll Surg       Date:  1954-11

3.  Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.

Authors:  B Cady; R L Jenkins; G D Steele; W D Lewis; M D Stone; W V McDermott; J M Jessup; A Bothe; P Lalor; E J Lovett; P Lavin; D C Linehan
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

4.  A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer.

Authors:  K Yasui; T Hirai; T Kato; A Torii; K Uesaka; T Morimoto; Y Kodera; Y Yamamura; T Kito; N Hamajima
Journal:  Ann Surg       Date:  1997-11       Impact factor: 12.969

5.  Resection of colorectal liver metastases: 25-year experience.

Authors:  B Ohlsson; U Stenram; K G Tranberg
Journal:  World J Surg       Date:  1998-03       Impact factor: 3.352

6.  Hepatic resection for metastases from colorectal carcinoma--a survival analysis.

Authors:  G R Jatzko; P H Lisborg; H M Stettner; M H Klimpfinger
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

7.  Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis.

Authors:  P Hohenberger; P M Schlag; T Gerneth; C Herfarth
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

8.  Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors.

Authors:  T J Gayowski; S Iwatsuki; J R Madariaga; R Selby; S Todo; W Irish; T E Starzl
Journal:  Surgery       Date:  1994-10       Impact factor: 3.982

9.  Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer.

Authors:  J Yamamoto; K Sugihara; T Kosuge; T Takayama; K Shimada; S Yamasaki; M Sakamoto; S Hirohashi
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

10.  Patient selection for hepatic resection of colorectal metastases.

Authors:  H J Wanebo; Q D Chu; M P Vezeridis; C Soderberg
Journal:  Arch Surg       Date:  1996-03
View more
  6 in total

1.  Resection margin with anatomic or nonanatomic hepatectomy for liver metastasis from colorectal cancer.

Authors:  Yoshihiro Inoue; Michihiro Hayashi; Koji Komeda; Shinsuke Masubuchi; Masashi Yamamoto; Hidenori Yamana; Hajime Kayano; Tetsunosuke Shimizu; Mitsuhiro Asakuma; Fumitoshi Hirokawa; Yoshiharu Miyamoto; Atsushi Takeshita; Yuro Shibayama; Kazuhisa Uchiyama
Journal:  J Gastrointest Surg       Date:  2012-02-28       Impact factor: 3.452

2.  Prognostic significance of histological categorization of desmoplastic reaction in colorectal liver metastases.

Authors:  Tadakazu Ao; Yoshiki Kajiwara; Keisuke Yonemura; Eiji Shinto; Satsuki Mochizuki; Koichi Okamoto; Suefumi Aosasa; Hideki Ueno
Journal:  Virchows Arch       Date:  2019-05-10       Impact factor: 4.064

3.  Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.

Authors:  Michihiro Hayashi; Yoshihiro Inoue; Koji Komeda; Tetsunosuke Shimizu; Mitsuhiro Asakuma; Fumitoshi Hirokawa; Yoshiharu Miyamoto; Junji Okuda; Atsushi Takeshita; Yuro Shibayama; Nobuhiko Tanigawa
Journal:  BMC Surg       Date:  2010-09-27       Impact factor: 2.102

4.  Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Masaru Miura; Yoshiro Fujii; Shigeki Yamaguchi; Itaru Endo; Hitoshi Sekido; Shinji Togo; Hideyuki Ike
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

5.  Histopathological prognostic factors for colorectal liver metastases: A systematic review and meta-analysis of observational studies.

Authors:  Cássio Virgílio Cavalcante de Oliveira; Gilton Marques Fonseca; Jaime Arthur Pirola Kruger; Evandro Sobroza de Mello; Fabricio Ferreira Coelho; Paulo Herman
Journal:  Histol Histopathol       Date:  2020-11-09       Impact factor: 2.303

6.  Predictors of recurrence after a first hepatectomy for colorectal cancer liver metastases: a retrospective analysis.

Authors:  Luis Cesar Bredt; Alex Francovig Rachid
Journal:  World J Surg Oncol       Date:  2014-12-20       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.